A pilot study exploring high-dose lenalidomide maintenance therapy in adult acute myeloid leukaemia (AML)

DOI number 10.58109/93av-pb36
Publisher Australasian Leukaemia and Lymphoma Group (ALLG)
Creator(s)

Australasian Leukaemia and Lymphoma Group (ALLG)

Andrew Wei (Alfred Hospital)

 
Date Made Available 2023
Dataset Individual participant data (IPD) in aggregate form
Description of Dataset

Dataset includes:

  • Data for 45 patients
  • Dose escalation study
  • Lenalidomide commenced in maintenance phase
  • Dataset includes demographic data, diagnostic, treatment data, outcome data
  • Disease and disease response measurements
  • Close monitoring of response to drug
  • Pathology design data
  • Clinical outcome measurements
Funding

Australasian Leukaemia and Lymphoma Group (ALLG)
Subject (ANZSRC Category)

Chemotherapy
ANZCTR Reference ACTRN12610000627055
Dataset Access

Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with this trial or email enquiries to info@allg.org.au
Memberships
Participate in a Trial
Memberships
Clinical Trials & Research
AMLM13
AMLM16